Form 4 for CVS CVS Health
Accepted 2025-04-03 00:00:00 ET · period of report 2025-04-01 · accession 0001127602-25-011413 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-03 | 2025-04-01 | CVS | Mandadi Tilak | EVP, Chief Experience, Tech | F - Tax | $67.98 | -995 | 43.5K | -2% | -$67.6K |
| D | 2025-04-03 | 2025-04-01 | CVS | Mandadi Tilak | EVP, Chief Experience, Tech | A - Grant | $67.98 | +20.6K | 116.3K | +22% | +$1.40M |
| D | 2025-04-03 | 2025-04-01 | CVS | Mandadi Tilak | EVP, Chief Experience, Tech | A - Grant | $67.98 | +87.3K | 87.3K | New | +$5.94M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-01 | F | D | 995 | $67.98 | 43,503 | D | — | — | |
| 2 | Common | Common Stock (RSU) | 2025-04-01 | A | A | 20,594 | $67.98 | 116,257 | D | — | — | |
| 3 | Derivative | Stock Option | 2025-04-01 | A | A | 87,336 | $67.98 | 87,336 | D | $67.98 · 2026-04-02 to 2035-04-01 | 87,336 Common Stock | (F3) Option becomes exercisable in four equal annual installments, commencing on 4/1/2026. |